4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-000910
EXEC. VP AND CLO sold 3,395 shares at an average $28.85 ($97,960)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boulding Mark Elliott EXEC. VP AND CLO | 2024-01-08 | Sale 10b5-1 | −1,457 | $28.64 | $41,729 | 73,921 | D |
| Boulding Mark Elliott EXEC. VP AND CLO | 2024-01-09 | Sale 10b5-1 | −1,938 | $29.01 | $56,231 | 71,983 | D |
| Open-market sales · 3,395 sh · avg $28.85 · $97,960 | |||||||
Loading xslF345X05/form4-01102024_090136.xml…